NEW YORK, 20 October 2021 / PRNewswire / – Colbeck Capital Management supported the 20th Melanoma Research Foundation (MRF) Gala on October 14, 2021. The annual event brings together members of the community to provide essential funding and support for the work being done to end melanoma. This year, the MRF celebrated past clinicians and research recipients, as well as many courageous melanoma patients who have shared their stories over the years. At present, the Gala has collected more than $ 1,300,000 from this year’s event only.
In addition to the 20th anniversary of the MRF Gala, it was also the 25th anniversary of the MRF itself. Over the past 25 years, the organization has been able to collect more than $ 20 million in research funds for academic institutions through United States. These funds have directly contributed to the development of more than 16 FDA-approved melanoma immunotherapy treatments.
Colbeck Capital Management was proud to support the 2021 MRF Gala and the important mission of the MRF to fund new research on melanoma. This is in line with Colbeck’s long-standing support for other prominent advocacy groups, including Pink Aid, the Children’s Tumor Foundation, and NEXT for Autism.
About the Melanoma Research Foundation
The Melanoma Research Foundation is the largest independent organization dedicated to melanoma. The MRF is an advocate for the melanoma community, helping to fund research and raise awareness about this disease and the need for a cure. MRF website is one of the best resources for melanoma information seekers.
About Colbeck Capital Management
Colbeck Capital Management (www.colbeck.com) is a strategic lender that partners with businesses during times of transition, providing creative capital solutions to meet their evolving needs. Founded in 2009 by Jason colodne and Jason beckman, Colbeck Capital has offices in New York City and Los Angeles.
SOURCE Colbeck Capital Management